Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4152302 | Current Paediatrics | 2006 | 5 Pages |
Abstract
SummaryNewborn screening for phenylketonuria has been available since the early 1960s. Advances in technology such as the introduction of tandem mass spectrometry have increased the number of conditions we are now able to screen for. More recently the possibility of genetic profiling of the newborn has been raised. This article looks at these changes and discusses some of the ethical issues that they raise.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Fiona Stewart,